Loading…
Portfolio as on Apr 2024 · 20 equity positions
Nippon India Nifty Pharma ETF is a ETF scheme managed by Nippon India MF Mutual Fund. As of disclosures dated Apr 2024, the scheme holds 20 equity positions with an estimated equity AUM of ₹₹639 Cr. The portfolio is anchored by its top conviction bet on Sun Pharmaceutical Industries, which commands a weight of 24.92%of the fund's total assets.
From a sector allocation perspective, the fund managers have concentrated their largest bet on Pharmaceuticals & Biotechnology, representing 100.00% of the equity portfolio. This is followed by. Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.
₹25.85 per unit +12.7% vs Jul '25
Last 365 days · daily NAV from AMFI · Nippon India Nifty Pharma ETF
Based on ~11 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio assumes a 6.5% risk-free rate. Past performance does not guarantee future returns — not investment advice.
Top 10 holdings make up 80.7% of the portfolio · top 5 = 61.8%.
Equity holdings only, ISIN-verified, from Nippon India Mutual Fund's public monthly portfolio disclosure (Apr 2024). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).